van Dongen Ja

646 total citations
19 papers, 504 citations indexed

About

van Dongen Ja is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, van Dongen Ja has authored 19 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in van Dongen Ja's work include Breast Cancer Treatment Studies (5 papers), Cutaneous Melanoma Detection and Management (3 papers) and Cancer Treatment and Pharmacology (3 papers) van Dongen Ja is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cutaneous Melanoma Detection and Management (3 papers) and Cancer Treatment and Pharmacology (3 papers) van Dongen Ja collaborates with scholars based in Netherlands van Dongen Ja's co-authors include J. Winter, Antoon Lerut, Fentiman Is, Harry Bartelink, F Mignolet, Richard Sylvester, G Olthuis, H. Bartelink, Kroon Bb and Peter Vuylsteke and has published in prestigious journals such as PubMed.

In The Last Decade

van Dongen Ja

17 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
van Dongen Ja Netherlands 6 385 212 204 187 73 19 504
J. R. Vilcoq France 8 347 0.9× 227 1.1× 165 0.8× 119 0.6× 35 0.5× 19 513
Mitchell Loeb Norway 9 252 0.7× 121 0.6× 199 1.0× 207 1.1× 69 0.9× 13 592
Joan G. Reid Canada 8 287 0.7× 179 0.8× 260 1.3× 135 0.7× 28 0.4× 8 577
Louise Cox United States 9 437 1.1× 232 1.1× 107 0.5× 226 1.2× 137 1.9× 10 532
Rebecca S.R. McDermot Canada 5 288 0.7× 163 0.8× 220 1.1× 108 0.6× 82 1.1× 8 437
H. Bartelink Netherlands 10 266 0.7× 147 0.7× 387 1.9× 394 2.1× 90 1.2× 35 763
Hp Macdonald United States 3 283 0.7× 157 0.7× 140 0.7× 128 0.7× 29 0.4× 6 360
A. Lisbona Canada 8 578 1.5× 507 2.4× 268 1.3× 344 1.8× 29 0.4× 18 796
A. Helen Westenberg Netherlands 11 334 0.9× 189 0.9× 220 1.1× 179 1.0× 18 0.2× 19 520
Monique Cohen France 16 547 1.4× 267 1.3× 266 1.3× 363 1.9× 27 0.4× 72 729

Countries citing papers authored by van Dongen Ja

Since Specialization
Citations

This map shows the geographic impact of van Dongen Ja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by van Dongen Ja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites van Dongen Ja more than expected).

Fields of papers citing papers by van Dongen Ja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by van Dongen Ja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by van Dongen Ja. The network helps show where van Dongen Ja may publish in the future.

Co-authorship network of co-authors of van Dongen Ja

This figure shows the co-authorship network connecting the top 25 collaborators of van Dongen Ja. A scholar is included among the top collaborators of van Dongen Ja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with van Dongen Ja. van Dongen Ja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bb, Kroon, et al.. (1994). Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?. PubMed. 4 Suppl 1. 13–6. 6 indexed citations
2.
Rutgers, Emiel J., et al.. (1994). Surgical treatment and deciding definitive management policy in a premenopausal patient with early breast cancer.. PubMed. 20(5). 607–9; discussion 609.
3.
Bb, Kroon, et al.. (1993). Regional isolated perfusion with melphalan for patients with subungual melanoma.. PubMed. 19(1). 37–42. 5 indexed citations
4.
Ja, van Dongen. (1993). Tumor markers--a tool for clinicians.. PubMed. 41(1). 27–27. 1 indexed citations
5.
Ja, van Dongen, Harry Bartelink, Fentiman Is, et al.. (1992). Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.. PubMed. 15–8. 344 indexed citations
6.
Vuylsteke, Peter, Ronald B. Keus, & van Dongen Ja. (1991). Desmoid tumours of the abdominal wall.. PubMed. 43(4). 117–20. 5 indexed citations
7.
Ja, van Dongen, et al.. (1991). Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases.. PubMed. 43(3). 51–5. 4 indexed citations
8.
Ja, van Dongen, et al.. (1991). Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation.. PubMed. 43(4). 102–4. 4 indexed citations
9.
Ja, van Dongen, et al.. (1988). Chest wall resection in the treatment of local recurrence of breast cancer.. PubMed. 14(2). 127–32. 30 indexed citations
10.
Bartelink, H., et al.. (1988). Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives.. PubMed. 14(2). 133–40. 89 indexed citations
11.
Ja, van Dongen, et al.. (1986). [In-situ ductal carcinoma of the breast; a retrospective clinico-pathological study].. PubMed. 130(7). 308–10. 3 indexed citations
12.
Ja, van Dongen, et al.. (1983). [Infraclavicular exploration as a prognostic criterion and as a selection criterion for choice of treatment in breast cancer].. PubMed. 127(17). 714–7.
13.
Ja, van Dongen, et al.. (1983). The role of surgery in advanced testicular cancer.. PubMed. 35(4). 129–33. 1 indexed citations
14.
Bb, Kroon, et al.. (1981). [Alveolar soft tissue sarcoma].. PubMed. 125(3). 87–93. 3 indexed citations
15.
Ja, van Dongen, et al.. (1980). [Melanomas in the anorectal area].. PubMed. 124(35). 1454–9. 1 indexed citations
16.
Ja, van Dongen, et al.. (1979). Staging laparotomies in Hodgkin's disease and non-Hodgkin's lymphoma: changing ideas on indication.. PubMed. 5(3). 201–8. 5 indexed citations
17.
Ja, van Dongen, et al.. (1973). Breast carcinoma--arguments for aggressive treatment.. PubMed. 25(4). 399–412. 1 indexed citations
18.
Ja, van Dongen, et al.. (1971). Dilemmas in the treatment of Hodgkin's disease.. PubMed. 14(2). 77–88. 1 indexed citations
19.
Ja, van Dongen, et al.. (1965). [SPONTANEOUS REMISSION OF METASTASIZED BREAST CANCER DUE TO PITUITARY METASTASES].. PubMed. 109. 506–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. R. Vilcoq Breakdown of academic impact, for papers by Mitchell Loeb Breakdown of academic impact, for papers by Joan G. Reid Breakdown of academic impact, for papers by Louise Cox Breakdown of academic impact, for papers by Rebecca S.R. McDermot Breakdown of academic impact, for papers by H. Bartelink Breakdown of academic impact, for papers by Hp Macdonald Breakdown of academic impact, for papers by A. Lisbona Breakdown of academic impact, for papers by A. Helen Westenberg Breakdown of academic impact, for papers by Monique Cohen
Rankless by CCL
2026